In the pivotal SUSTAIN trials examining semaglutide for type 2 diabetes management, vomiting was reported in 5-9% of patients receiving therapeutic doses (0.5 mg or 1 mg weekly subcutaneous injections), compared to approximately 2-3% in placebo groups
Pistollato F, Abbadi S, Rampazzo E, Persano L, Della Puppa A, Frasson C, et al
Protection from Free Radicals: The glutathione antioxidants are effective in helping to protect the skin against the negative UV radiation and environmental pollutants, which can cause premature aging and damage to the skin
GLP-1 medications are peptides large molecules that cant effectively penetrate the skin and must be delivered through an injection or through specially formulated pills
They might forget main details, big ideas, or whole talks that happened not long ago